BioPharma Dive19h
CMS says private Medicare plans can’t automatically deny Biogen’s ALS drug
In a rare move, the U.S. agency behind Medicare is warning Medicare Advantage providers they can’t have blanket policies that ...
BioPharma Dive20h
Dietmar Berger is Gilead’s new CMO; Padlock investors sue Bristol Myers
Gilead CEO Daniel O’Day has hired Berger away from Sanofi. Elsewhere, Lonza is reorganizing and Bausch + Lomb is exploring a ...
BioPharma Dive20h
FDA panel seeks more data on RSV vaccine safety in infants
After several severe RSV cases were reported in a pediatric trial of Moderna's vaccine, the FDA has partially paused testing ...
BioPharma Dive21h
AbbVie to acquire Roche spinout Nimble in immune drug deal
The pharma will pay $200 million to buy Nimble and a preclinical oral drug that blocks a protein known as IL-23 — the target ...